NCT05539261

Brief Summary

The purpose of this study is to clarify the changes of neurocognitive function of patients undergoing cardiac valve disease before and after surgical treatment under cardiopulmonary bypass operation, and to predict the neurological prognosis of such patients through combined imaging technology, so as to improve and avoid the occurrence of postoperative neurological dysfunction in such patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

September 10, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

3.3 years

First QC Date

September 5, 2022

Last Update Submit

September 10, 2022

Conditions

Keywords

Heart Valve DiseasesCardiopulmonary bypassMRI ImagingNeuropsychological assessment

Outcome Measures

Primary Outcomes (2)

  • Change of brain volume before and after operation

    The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • Change of brain function connectivity before and after operation

    The change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.

    before operation; 7-10 Days after operation; 1 month; 6-12months

Secondary Outcomes (10)

  • Change of brain evaluate basic cognition before and after operation

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • Change of executive functions before and after operation evaluated by Trail-Making Test Part A

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • Change of executive functions before and after operation evaluated by Digit Symbol Coding score

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • Change of working memory before and after operation evaluated by Forward Digit Span

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • Change of working memory before and after operation evaluated by Backward Digit Span

    before operation; 7-10 Days after operation; 1 month; 6-12months

  • +5 more secondary outcomes

Study Arms (2)

HVD

Heart Valve Disease

Device: magnetic resonance imageDiagnostic Test: Neuropsychological scale

HC

Healthy controls

Device: magnetic resonance imageDiagnostic Test: Neuropsychological scale

Interventions

Imaging data were collected in a strong magnetic field

HCHVD

Multi dimensional neuropsychological test

HCHVD

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All of the patients of HVD group are in-patients and out-patients in the cardiac surgery department from the research center. The subjects of control group are recruited from community.

You may qualify if:

  • Aged 45-80 years old.
  • Accept heart biological valve replacement or heart valvuloplasty.
  • More than 6 years of Education.
  • At baseline, the score of Mini-mental State Examination (MMSE) scale is more than 23 points

You may not qualify if:

  • Patients who failed to obtain informed consent.
  • Preoperative diagnosis of stroke, epilepsy, history of craniocerebral surgery, cerebrovascular disease, psychosis and rescue patients with cardiopulmonary resuscitation before operation.
  • Alcoholism, illiteracy and left-handed.
  • There was severe organ hypoperfusion or organ dysfunction before operation, including: preoperative myocardial infarction \< 90 days, renal failure or dialysis, severe liver injury, digestive tract ischemia, spinal cord ischemia and iliac artery occlusion.
  • There are contraindications to magnetic resonance examination, such as claustrophobia and metal implants in the body.
  • Pregnant or lactating women.
  • Participating in other clinical studies will affect the main indicators of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuncheng First Hospital

Yuncheng, Shanxi, China

Location

MeSH Terms

Conditions

Heart Valve Diseases

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Nengrui Guo

    Yuncheng First Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investgator

Study Record Dates

First Submitted

September 5, 2022

First Posted

September 14, 2022

Study Start

September 10, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 14, 2022

Record last verified: 2022-09

Locations